Related Experiment Video
Updated: Jun 19, 2026

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System
Published on: July 30, 2018
Antitumor effects of a recombinant pseudotype baculovirus expressing Apoptin in vitro and in vivo
Yongfei Pan1, Liurong Fang, Huiying Fan
1Division of Animal Infectious Diseases, State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, People's Republic of China.
Abstract:
Apoptin, a chicken anemia virus-derived, p53-independent, bcl-2-insenstive apoptotic protein with the ability to specifically induce apoptosis in tumor or transformed cells, is a promising tool for cancer gene therapy. In this study, pseudotype baculovirus, a recently developed alternative gene delivery system, was used as a vector to express Apoptin. The resultant recombinant baculovirus (BV-Apoptin) efficiently expressed the Apoptin protein and induced apoptosis in HepG2 and H22 cells. Studies in vivo showed that intratumoral injection of BV-Apoptin into a xenogeneic tumor (derived from H22 murine hepatoma cells in C57BL/6 mice) significantly suppressed tumor growth, and significantly prolonged the survival of tumor-bearing mice compared to a control pseudotype baculovirus that expressed EGFP. Taken together, these results suggest that Apoptin, expressed from the pseudotype baculovirus vector, has the potential to become a therapeutic agent for the treatment of solid tumors.
Insights
Apoptin, a novel protein, effectively triggers cancer cell death independently of p53. When delivered via a pseudotype baculovirus vector, Apoptin demonstrated significant tumor suppression and improved survival in preclinical models, highlighting its potential in cancer gene therapy.
Area of Science:
- Oncology
- Virology
- Gene Therapy
Background:
- Apoptin, derived from chicken anemia virus, induces apoptosis in tumor cells independent of p53 and Bcl-2.
- Gene therapy offers a promising avenue for cancer treatment, requiring efficient and specific delivery vectors.
Purpose of the Study:
- To evaluate the efficacy of Apoptin delivered by a pseudotype baculovirus vector for cancer treatment.
- To assess the in vitro and in vivo anti-tumor activity of the recombinant baculovirus expressing Apoptin.
Main Methods:
- Construction of a recombinant pseudotype baculovirus (BV-Apoptin) expressing Apoptin.
- In vitro apoptosis induction assays in HepG2 and H22 cancer cell lines.
- In vivo studies involving intratumoral injection of BV-Apoptin in a xenogeneic mouse tumor model.
Main Results:
- BV-Apoptin efficiently expressed Apoptin and induced apoptosis in cancer cells.
- Intratumoral injection of BV-Apoptin significantly suppressed tumor growth in mice.
- Treatment with BV-Apoptin significantly prolonged the survival of tumor-bearing mice compared to control.
Conclusions:
- Apoptin delivered via pseudotype baculovirus exhibits potent anti-tumor activity.
- BV-Apoptin demonstrates potential as a therapeutic agent for solid tumors.
- This study supports the development of Apoptin-based gene therapy for cancer treatment.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway

